Skip to main content
L

Not yet reviewed: this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

Propoxyphene

This article is a stubmissing:
Subjective Effects
Interactions
Tolerance
Propoxyphene molecule structurePropoxyphene molecule structure
Chemical Class

Propoxyphene is a weak opioid analgesic and depressant1 of the diphenylpropylamine class2. It is used to treat mild pain3 and also has cough suppressant and local anaesthetic effects. Its pain-relieving activity is lower than that of codeine. It is habit-forming3 and carries risks of fatal overdose3 and heart arrhythmias.3

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold~30 mg
Light30-65 mg
Moderate65-100 mg
Strong100-200 mg
Heavy200+ mg

Duration

Onset20-30 minutes
After Effects2-6 hours
Total1-3 hours

Subjective Effects

Subjective Effects not written up yet

Reagent Testing

Expected colorimetric results for common reagent tests. Colors show reaction change over 1–2 minutes.

Marquis(MQ)
white → black3 → purple2 → green2
Mandelin(MD)
yellow2 → black2 → brown2
Liebermann(LB)
white → brown2
Powered by PROtestkit.eu

Pharmacology

Pharmacodynamics

Propoxyphene acts as a μ-opioid receptor agonist.4 It also potently blocks α3β4 neuronal nicotinic acetylcholine receptors through a noncompetitive mechanism and weakly inhibits serotonin reuptake. It blocks cardiac sodium channels5 and has local anesthetic activity at concentrations approximately ten times those needed for opioid effects.6

Pharmacokinetics

Propoxyphene napsylate is very slightly soluble in water.7 Propoxyphene can remain detectable for up to nine days after the last dose, with trace amounts potentially persisting longer.

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Addiction & Dependence

Psychological

Propoxyphene is habit-forming and has recognized addiction potential.8

Toxicity

Lethal Dosage

Small increases above the therapeutic dose can cause severe toxicity and fatal overdose. Fatalities have also occurred when patients with depression or suicidal tendencies misused propoxyphene.

Cardiovascular

Propoxyphene can cause cardiac arrhythmias at typical doses, while poisoning can decrease heart rate, contractility, and cardiac electrical conduction; severe cardiotoxicity can occur with small increases above the therapeutic dose.

Central nervous system

Propoxyphene poisoning causes central nervous system depression.9

Respiratory

Propoxyphene poisoning can cause respiratory depression,10 aspiration pneumonia, and pulmonary edema.

Seizure Risk

Seizures can occur in propoxyphene poisoning10 and may arise from opioid or local anesthetic effects.

History & Culture

Early research and commercial development

Dextropropoxyphene was successfully tested in 1954 during research funded by the US Navy and CIA to find nonaddictive alternatives to codeine. It was patented in 195511 and manufactured by Eli Lilly and Company.12…

Legality

International

European and U.S. markets removed propoxyphene because of fatal-overdose and heart-arrhythmia concerns.

By Country

Illegal1
United States flagUnited StatesIllegal

References

Citations

  1. PROPOXYPHENE NAPSYLATE AND ACETOMINOPHEN tablet, film coated. DailyMed (2004). https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4cf33260-5a78-4207-b113-a9d6771811a31
  2. Dextropropoxyphene (PIM 442F, French). IPCS INCHEM (n.d.). https://www.inchem.org/documents/pims/pharm/pim442fr.htm1
  3. PROPOXYPHENE- propoxyphene hydrochloride capsule. DailyMed (2009). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f60e8f65-a12b-4073-ac0f-81e1186617d71234
  4. PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN tablet, film coated. DailyMed (2009). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48237a1b-a9e3-4123-a041-a49eeca8d84c1
  5. Marked QRS Complex Abnormalities and Sodium Channel Blockade by Propoxyphene Reversed with Lidocaine. Journal of Clinical Investigation (1989). https://itlab.us/pubs/propoxyphene.pdf12
  6. PROPOXYPHENE. JoDrugs (n.d.). https://www.jodrugs.com/toxicologies/3799-propoxyphene.aspx1
  7. DARVON-N (Propoxyphene Napsylate Tablets, USP). U.S. Food and Drug Administration (2009). https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/016862s041s042lbl.pdf1
  8. DARVON-N - propoxyphene napsylate tablet, film coated. DailyMed (2009). https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=c6c48eee-240b-4425-8691-35462523652e1
  9. Propoxyphene HCl and Acetaminophen Tablets USP. DailyMed (2003). https://www.dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=a1a85756-9773-4fbf-ab52-f29eb2a92413&type=display1
  10. Propoxyphene Suicides: Report of Nine Cases. Archives of Internal Medicine (1972). https://doi.org/10.1001/archinte.1972.0032001006600612

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed: this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Propoxyphene article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.